Fibrogen-depleted Human Platelet Lysate
Ian Copland, MD; Jacques Galipeau, MD; John Roback, MD, PhD; Edmund Waller, MD, PhD
Chronic dry eye, a common eye disease, is a leading cause of patient visits to eye practitioners. The disease causes dry, burning, gritty, stingy, scratchy sensations and has no cure. Emory inventors developed a technology to treat the disease that uses the regenerative components of platelets that is being developed as a topical biologic ophthalmic drop. Emory licensed this technology to Cambium Medical Technologies in 2014.